Cancer proteomics by quantitative shotgun proteomics.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 18443658)

Published in Mol Oncol on September 01, 2007

Authors

Emily I Chen1, John R Yates

Author Affiliations

1: Department of Cell Biology, 10550 North Torrey Pines Road, SR11, The Scripps Research Institute, La Jolla, CA 92037, USA.

Articles citing this

Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol (2009) 2.72

Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol (2008) 2.01

Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification. Clin Cancer Res (2011) 1.50

Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics (2010) 1.27

Phosphoproteomics in cancer. Mol Oncol (2010) 1.12

On-beads digestion in conjunction with data-dependent mass spectrometry: a shortcut to quantitative and dynamic interaction proteomics. Biology (Basel) (2014) 1.00

MALDI imaging mass spectrometry--painting molecular pictures. Mol Oncol (2010) 0.96

Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling. Br J Cancer (2014) 0.88

Impact of peptide modifications on the isobaric tags for relative and absolute quantitation method accuracy. Anal Chem (2011) 0.83

Proteomics approaches for the studies of bone metabolism. BMB Rep (2014) 0.82

Proteomic analysis of effects by x-rays and heavy ion in HeLa cells. Radiol Oncol (2014) 0.82

Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol. J Proteome Res (2014) 0.81

Proteomic analysis of energy metabolism and signal transduction in irradiated melanoma cells. Int J Ophthalmol (2013) 0.79

Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis. Int J Proteomics (2014) 0.77

A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research. Front Oncol (2017) 0.75

State of the art in tumor antigen and biomarker discovery. Cancers (Basel) (2011) 0.75

QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues. Mol Cell Proteomics (2015) 0.75

Articles cited by this

(truncated to the top 100)

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom (1994) 45.51

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30

A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem (2003) 29.58

Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol (1999) 21.92

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell (2006) 20.92

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70

A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem (2004) 19.20

The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics (2002) 16.08

Oncogenes and signal transduction. Cell (1991) 14.84

Met, metastasis, motility and more. Nat Rev Mol Cell Biol (2003) 14.30

Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol (1999) 12.42

DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J Proteome Res (2003) 12.31

A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol (2006) 12.13

Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res (2003) 11.96

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A (2003) 10.82

Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67

A proteomic view of the Plasmodium falciparum life cycle. Nature (2002) 10.65

A proteomics approach to understanding protein ubiquitination. Nat Biotechnol (2003) 10.51

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics (2005) 8.92

How proteolysis drives the cell cycle. Science (1996) 8.59

Mass spectrometry and protein analysis. Science (2006) 8.05

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol (2004) 7.69

Chromosome aberrations in solid tumors. Nat Genet (2003) 7.01

An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem (2001) 6.90

Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer (2004) 6.67

Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science (2007) 6.65

Epidermal growth factor receptor (EGFR) signaling in cancer. Gene (2005) 6.04

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer (2001) 5.96

The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res (1998) 5.86

Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci U S A (1999) 5.43

Functions of the proteasome: the lysis at the end of the tunnel. Science (1995) 5.29

Analysis of phosphorylation sites on proteins from Saccharomyces cerevisiae by electron transfer dissociation (ETD) mass spectrometry. Proc Natl Acad Sci U S A (2007) 5.09

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis (1997) 5.06

Current two-dimensional electrophoresis technology for proteomics. Proteomics (2004) 4.87

The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J (1997) 4.80

Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Acad Sci U S A (1999) 4.76

Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem (2003) 4.72

Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat Methods (2004) 4.62

The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics (2004) 4.48

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol (2006) 4.47

Novel linear quadrupole ion trap/FT mass spectrometer: performance characterization and use in the comparative analysis of histone H3 post-translational modifications. J Proteome Res (2004) 4.32

Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal Chem (2005) 4.16

Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem (1996) 3.97

Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem (1997) 3.76

A two-dimensional quadrupole ion trap mass spectrometer. J Am Soc Mass Spectrom (2002) 3.65

Large-scale database searching using tandem mass spectra: looking up the answer in the back of the book. Nat Methods (2004) 3.62

Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors. Methods (2006) 3.37

Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal Chem (2003) 3.33

Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol (2001) 3.14

Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4. Anal Chem (2006) 3.08

Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal Chem (2006) 3.03

Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Anal Chem (2002) 2.94

A correlation algorithm for the automated quantitative analysis of shotgun proteomics data. Anal Chem (2003) 2.89

The utility of ETD mass spectrometry in proteomic analysis. Biochim Biophys Acta (2006) 2.85

Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS. Drug Discov Today (2004) 2.82

Hepatic Golgi fractions resolved into membrane and content subfractions. J Cell Biol (1982) 2.75

Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics (2005) 2.66

The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem (2005) 2.64

Top-down mass spectrometry of a 29-kDa protein for characterization of any posttranslational modification to within one residue. Proc Natl Acad Sci U S A (2002) 2.62

Global analysis of protein sumoylation in Saccharomyces cerevisiae. J Biol Chem (2004) 2.60

Improving reproducibility and sensitivity in identifying human proteins by shotgun proteomics. Anal Chem (2004) 2.53

Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol (1997) 2.52

Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J Proteome Res (2003) 2.51

A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot (2006) 2.50

Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res (2006) 2.43

Maspin is an angiogenesis inhibitor. Nat Med (2000) 2.40

Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem (2004) 2.40

Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle (2005) 2.35

New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J Proteome Res (2006) 2.33

Mass spectrometric characterization of human histone H3: a bird's eye view. J Proteome Res (2006) 2.29

Statistical and computational methods for comparative proteomic profiling using liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics (2005) 2.24

Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res (2005) 2.22

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20

Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol (1998) 2.19

Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14

The proteasome as a target for cancer therapy. Clin Cancer Res (2003) 2.13

Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics (2006) 2.11

Effects of modified digestion schemes on the identification of proteins from complex mixtures. J Proteome Res (2006) 2.09

Changes in the protein expression of yeast as a function of carbon source. J Proteome Res (2003) 2.07

Quantitative analysis of bacterial and mammalian proteomes using a combination of cysteine affinity tags and 15N-metabolic labeling. Anal Chem (2001) 2.06

Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics (2003) 2.04

Performance of a linear ion trap-Orbitrap hybrid for peptide analysis. Anal Chem (2006) 2.03

Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics (2004) 2.00

Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue. Biomed Mass Spectrom (1983) 1.90

Peptide mass maps: a highly informative approach to protein identification. Anal Biochem (1993) 1.89

Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol (2006) 1.82

Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat Biotechnol (2005) 1.76

Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic (2006) 1.73

Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal Chem (2004) 1.72

Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev (2003) 1.70

Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci U S A (2003) 1.68

Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol (2004) 1.64

Detection of secreted peptides by using hypothesis-driven multistage mass spectrometry. Proc Natl Acad Sci U S A (2003) 1.63

Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res (2004) 1.62

Biomarker discovery in urine by proteomics. J Proteome Res (2003) 1.57

Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res (2002) 1.57

Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat (1987) 1.54

Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun Mass Spectrom (2002) 1.54

Gene-specific characterization of human histone H2B by electron capture dissociation. J Proteome Res (2006) 1.53

Articles by these authors

(truncated to the top 100)

A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem (2004) 19.20

Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (2003) 12.54

DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J Proteome Res (2003) 12.31

A proteomic view of the Plasmodium falciparum life cycle. Nature (2002) 10.65

The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol (2007) 10.24

Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature (2002) 8.92

A role for the P-body component GW182 in microRNA function. Nat Cell Biol (2005) 7.54

Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science (2002) 7.49

The human CENP-A centromeric nucleosome-associated complex. Nat Cell Biol (2006) 6.85

A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol (2003) 6.32

A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science (2005) 5.99

Phospho-regulation of kinetochore-microtubule attachments by the Aurora kinase Ipl1p. Cell (2002) 5.91

A conserved protein network controls assembly of the outer kinetochore and its ability to sustain tension. Genes Dev (2004) 5.23

Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature (2005) 5.15

Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell (2009) 5.05

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell (2006) 5.01

Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science (2004) 4.97

The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell (2004) 4.91

The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres. Nat Cell Biol (2006) 4.89

MS1, MS2, and SQT-three unified, compact, and easily parsed file formats for the storage of shotgun proteomic spectra and identifications. Rapid Commun Mass Spectrom (2004) 4.76

Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat Methods (2004) 4.62

Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol (2011) 4.59

Assigning function to yeast proteins by integration of technologies. Mol Cell (2003) 4.58

Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol Cell (2009) 4.57

Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation. Nature (2008) 4.52

Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in multiple small-RNA-mediated pathways. Cell (2006) 4.50

Global analysis of protein palmitoylation in yeast. Cell (2006) 4.43

PRAK is essential for ras-induced senescence and tumor suppression. Cell (2007) 4.30

The biological impact of mass-spectrometry-based proteomics. Nature (2007) 4.24

Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2. Mol Cell (2007) 4.22

Centromere-specific assembly of CENP-a nucleosomes is mediated by HJURP. Cell (2009) 4.22

Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21

Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network. Dev Cell (2007) 4.17

The Set2 histone methyltransferase functions through the phosphorylated carboxyl-terminal domain of RNA polymerase II. J Biol Chem (2003) 4.13

Probability-based validation of protein identifications using a modified SEQUEST algorithm. Anal Chem (2002) 3.86

Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science (2008) 3.77

Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res (2009) 3.77

Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci U S A (2002) 3.70

Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science (2003) 3.64

Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res (2004) 3.63

Large-scale database searching using tandem mass spectra: looking up the answer in the back of the book. Nat Methods (2004) 3.62

A systematic approach to modeling, capturing, and disseminating proteomics experimental data. Nat Biotechnol (2003) 3.57

Molecular architecture of the human pre-mRNA 3' processing complex. Mol Cell (2009) 3.52

Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science (2007) 3.46

Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface. Mol Cell (2010) 3.44

Distinct argonaute-mediated 22G-RNA pathways direct genome surveillance in the C. elegans germline. Mol Cell (2009) 3.43

A quantitative analysis software tool for mass spectrometry-based proteomics. Nat Methods (2008) 3.35

A complex containing the Sm protein CAR-1 and the RNA helicase CGH-1 is required for embryonic cytokinesis in Caenorhabditis elegans. J Cell Biol (2005) 3.18

Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell (2008) 3.11

Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A (2007) 3.08

Arginylation of beta-actin regulates actin cytoskeleton and cell motility. Science (2006) 3.05

A streamlined platform for high-content functional proteomics of primary human specimens. Nat Methods (2005) 3.00

Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98

Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Anal Chem (2002) 2.94

Architecture of the budding yeast kinetochore reveals a conserved molecular core. J Cell Biol (2003) 2.92

A hypergeometric probability model for protein identification and validation using tandem mass spectral data and protein sequence databases. Anal Chem (2003) 2.91

Mass spectrometry in high-throughput proteomics: ready for the big time. Nat Methods (2010) 2.91

A correlation algorithm for the automated quantitative analysis of shotgun proteomics data. Anal Chem (2003) 2.89

Proteomic analysis of isolated chlamydomonas centrioles reveals orthologs of ciliary-disease genes. Curr Biol (2005) 2.86

TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium. Mol Biol Cell (2005) 2.76

GutenTag: high-throughput sequence tagging via an empirically derived fragmentation model. Anal Chem (2003) 2.74

Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2003) 2.73

Automatic quality assessment of peptide tandem mass spectra. Bioinformatics (2004) 2.70

Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70

Tea4p links microtubule plus ends with the formin for3p in the establishment of cell polarity. Dev Cell (2005) 2.65

The application of mass spectrometry to membrane proteomics. Nat Biotechnol (2003) 2.61

Global analysis of protein sumoylation in Saccharomyces cerevisiae. J Biol Chem (2004) 2.60

LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron (2009) 2.60

Swi1 and Swi3 are components of a replication fork protection complex in fission yeast. Mol Cell Biol (2004) 2.55

Code developments to improve the efficiency of automated MS/MS spectra interpretation. J Proteome Res (2003) 2.53

The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res (2008) 2.53

RNA-dependent cysteine biosynthesis in archaea. Science (2005) 2.50

Deubiquitination of histone H2B by a yeast acetyltransferase complex regulates transcription. J Biol Chem (2003) 2.48

Digestion and depletion of abundant proteins improves proteomic coverage. Nat Methods (2012) 2.48

Replication-independent histone deposition by the HIR complex and Asf1. Curr Biol (2005) 2.40

Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem (2004) 2.40

Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci U S A (2003) 2.38

Validation of tandem mass spectrometry database search results using DTASelect. Curr Protoc Bioinformatics (2007) 2.37

Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science (2009) 2.37

ZW10 links mitotic checkpoint signaling to the structural kinetochore. J Cell Biol (2005) 2.36

Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat Struct Biol (2003) 2.32

Mass spectrometry for proteomics. Curr Opin Chem Biol (2008) 2.31

Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain. Nat Cell Biol (2004) 2.30

A hormone-dependent module regulating energy balance. Cell (2011) 2.30

PYR/PYL/RCAR family members are major in-vivo ABI1 protein phosphatase 2C-interacting proteins in Arabidopsis. Plant J (2009) 2.29

Molecular analysis of kinetochore architecture in fission yeast. EMBO J (2005) 2.29

Proteomic survey of metabolic pathways in rice. Proc Natl Acad Sci U S A (2002) 2.27

Cid13 is a cytoplasmic poly(A) polymerase that regulates ribonucleotide reductase mRNA. Cell (2002) 2.23

Statistical characterization of ion trap tandem mass spectra from doubly charged tryptic peptides. Anal Chem (2003) 2.20

One-step affinity purification of the yeast ribosome and its associated proteins and mRNAs. RNA (2002) 2.19

Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med (2011) 2.17

Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res (2007) 2.17

The human kinetochore Ska1 complex facilitates microtubule depolymerization-coupled motility. Dev Cell (2009) 2.14

PatternLab for proteomics: a tool for differential shotgun proteomics. BMC Bioinformatics (2008) 2.13

TFG-1 function in protein secretion and oncogenesis. Nat Cell Biol (2011) 2.13

Protein analysis by shotgun/bottom-up proteomics. Chem Rev (2013) 2.13

Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J (2007) 2.07

Dephosphorylation of F-BAR protein Cdc15 modulates its conformation and stimulates its scaffolding activity at the cell division site. Mol Cell (2010) 2.02

Cleavage N-terminal to proline: analysis of a database of peptide tandem mass spectra. Anal Chem (2003) 1.98

The novel SLIK histone acetyltransferase complex functions in the yeast retrograde response pathway. Mol Cell Biol (2002) 1.98